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Ia  region  gene  products  have  long  been  postulated  to  be  antigen-binding 
(recognition) molecules (1); in particular, one set of hypotheses suggests that they 
are participants along with a  T  cell product in the antigen-binding complex (2, 
3). It has recently been observed that certain T  cell clones will react to antigen 
in  association  with  two  different  major  histocompatibility  complex  (MHC) 1 
haplotypes, but in doing so these clones display different antigen specificities (4, 
5).  Such results have been interpreted as support  for the above hypothesis. In 
the present work we have subjected the postulate to a further test by attempting 
to identify the site on a  peptide antigen that interacts with the Ia molecule (i.e. 
controls the specificity changes that accompany the changes of MHC type) and 
the presumably different site that interacts with the T  cell (i.e.  contributes  to 
immune memory). 
In our initial studies, the nominal antigens were peptides consisting of residues 
81-104  or  81-103  of the  cytochrome c  from  pigeon  or  moth,  respectively. 
B10.A  mice  immunized with low doses of either the pigeon  81-104  or moth 
81-103  responded  to both moth and pigeon fragments. However,  B10.A(5R) 
mice immunized with low doses of pigeon fragment showed no response at all. 
When  B10.A(5R)  mice were  immunized with large doses of moth  fragment a 
strong response was seen, but this immune response showed no cross-reactivity 
with the pigeon peptide.  IL2-secreting T  cell hybridomas from a  moth-primed 
B10.A(5R)  or  a  pigeon-primed  B10.A  mouse  were  prepared  and  tested  with 
antigen-presenting cells (APC) of these two strains. It was found that the T  cell 
hybridomas from either strain responded to antigen associated with either B 10.A 
or B10.A(5R) APC but to no others (5). Surprisingly, the specificity pattern was 
determined not by the MHC genes of the T  cell hybridoma but by those of the 
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APC. Subsequently, Heber-Katz et al. (6) have extended these observations by 
showing that peritoneal exudate T  lymphocytes (PETLES) from pigeon-primed 
B10.A and moth-primed B10.A(5R) mice behave in a manner indistinguishable 
from the T  cell hybridomas when antigen responses with different APC were 
tested. 
These observations provide the means for identifying two different functional 
sites on the pigeon cytochrome c fragment. They can be used to locate the site 
wherein moth and pigeon differ structurally, which prevents the pigeon fragment 
from being presented to these T  cells by B10.A(5R) APC. There is a second site, 
functionally defined by  T  cell  memory and shared by the  moth and  pigeon 
fragments, to which this population of T  cells has been primed. In the present 
work synthetic peptides were prepared and tested in order to identify these two 
sites. 
The difference between the moth and pigeon peptides that controlled APC 
functions was found to be at residue 103. At this position the pigeon sequence 
contains alanine,  which is  deleted from the moth peptide.  The site of T  cell 
memory was also identified. By introducing changes in the lysines at 99 and 103 
and at 99 alone, two additional pairs of antigen peptides were made, each pair 
consisting of otherwise homologous sequences with and without alanine-103. 
The immune response pattern of the B10.A(5R) was duplicated for these new 
antigens;  the  B10.A(5R)  was  a  low  responder  to  the  alanine-103  containing 
peptides, but a high responder to the des-Ala  l°a peptides. When B 10.A(SR) mice 
were primed with the des-Ala  1°3 peptides, the two new antigens did not cross- 
react with  des-Alal°3-pigeon  81-104  or  with  each other.  The  mothlike  (des- 
Ala ~°~) and pigeonlike forms of these two new antigens were found to behave 
just as the moth and pigeon fragments themselves behaved when tested for their 
ability to be presented by either B10.A or B10.A(5R) APC. Thus, both forms 
were presented by the B10.A APC but only mothlike, des-Ala  ~°s peptides were 
presented to the B10.A(5R) T  cells by syngeneic APC. When these experiments 
were extended by testing T  lymphocyte hybridoma clones similar behavior of 
the Ala  ~°3 deletion was observed. However, additional residues also appeared to 
be able to affect the APC's function. 
A prominent and interesting feature of our initial studies was that the T  cell 
populations from the B10.A and B10.A(5R) primed to pigeon 81-104 and moth 
81-103,  respectively appeared  to  be  equivalent.  We  naturally wished to  see 
whether this equivalence extended to the new antigens. For the new antigen in 
which lysine-99 was replaced by glutamine, the B 10.A and B 10.A(5R) repertoires 
were found not to be symmetrical. Rather the B10.A(SR) APC presented both 
the Alal°3-Gln  99 and des-Alal°3-Gln  99 antigens to B 10.A T  cells primed with the 
Alal°3-Gln  99.  Since  the  B10.A(5R)  was  a  low  responder  to  the  Alal°S-Gln  99 
antigen,  these  data  indicate  that  while  Ir differences to  some antigens (e.g., 
pigeon and moth) are expressed solely in the APC, this is not invariably the case. 
Materials and Methods 
Animals.  C57BLI0/Sn, B10.A/SgSn, B10.A(4R)/SgSn, and B10.A(SR)/SgSn mice 
were obtained through contracts provided by the National  Institutes of Health, Small 
Animal  Branch,  Frederick Cancer Research Center, Frederick, MD.  B10.S(9R)/SgSn HANSBURG  ET AL.  27 
were a gift from Dr. C. David, Mayo Foundation, Rochester, MN. 
Antigens.  Preparation of antigens has been described elsewhere (7). Briefly, the car- 
boxyl terminal cyanogen bromide fragment from pigeon (Columbia livia)  was prepared 
from the isolated protein, kindly provided by Dr. E. Margoliash, Northwestern University, 
Evanston,  IL.  The  other  peptides  were  synthesized  by  the  method  of Merrifield as 
described previously (5) except that the tyrosine hydroxyls were protected as 2,6-dichlo- 
robenzyl ethers and the amide functions were protected as the 9-xanthenyl amido ester 
(8). Peptides having 16 or fewer residues could be purified from the hydrogen fluoride- 
treated solid-phase reaction mixture by a single gel-filtration chromatography step (Seph- 
adex G-25, fine, 2.5 x  100 cm) in  5% (vol/voi) acetic acid. The larger peptides were 
further purified on CM-BioGel A as previously described. The acetimidyl derivatives were 
prepared by reaction of the peptide with methyl acetimidate HCI (Aldrich Chemical Co., 
Milwaukee,  WI).  The conditions used  allowed reaction only with  the  primary amino 
groups, thereby converting each lysine into an analogue of homoarginine. 
Preparation  and  Culture  of Peritoneal  Exudate  T  Lymphocyte-enriched Cells  (PETLES). 
PETLES were prepared as previously described (9). Animals were immunized in the hind 
foot pad with antigen and complete Freund's adjuvant followed 10 d later by an injection 
of  1.0  ml  10%  (wt/voi)  Brewer's thioglycolate medium  intraperitoneaily. After  5  d, 
exudate cells were removed from the peritoneum and passed over nylon wool. 5 x  104 
nylon wool passed iymphocytes were cultured in 0.2 ml Eagle's Hanks amino acids medium 
(EHAA) containing  10%  fetal  bovine  serum  and  varying numbers  of antigen.pulsed 
presenting cells. After 90 h of culture 1 •Ci  of [SH]thymidine was added to each culture 
and 6 h later the cultures were harvested using a MASH II (MA Bioproducts, Walkersville, 
MD). 
Preparation  of Antigen-presenting  and  an  Antigen-pulsing  Procedure.  According  to the 
method of DeFranco (10) spleens were teased, washed twice with l~hosphate-buffered 
saline without Ca  *+ or Mg++(PBS) (MA Bioproducts) and then 5 x  107 cells were layered 
in 3 ml of PBS above 3 ml of a solution (Percoll, 10X PBS, PBS-9:I:10 [vol/vol]) and 
then centrifuged for 12 min at 4°C at 2,000 g. The cells that banded at the PBS/Percoll 
interface were greatly enriched for antigen-presenting activity (L. Glimcher, unpublished 
observation). These were washed three times with PBS, and cultured with antigen 15 h 
at 37°C in complete medium, washed six times and then irradiated (2,000 R). 
Preparation  of T  Cell Hybridomas  and Assessment of Antigen-specific Stimulation.  T  cell 
hybridomas were made as described previously (5,  11,  12).  Briefly, lymph node T  cell 
cultures stimulated with antigen for 3 d were fused with BW5147 and selected by growth 
in hypoxanthine, aminopterin, thymidine (HAT) medium. Fusion products were cloned 
by limiting dilution on a thymocyte feeder layer. Antigen specificity was tested by first 
culturing 5 x  104-105 T  cell hybrids and 5 ×  105 X-irradiated spleen cells in 0.25 ml of 
fusion medium without HAT for 2 d with varying amounts of antigen. The supernatant 
from these cultures was harvested and added to an equal volume of complete EHAA in a 
second culture to assess IL2 production. This culture contained 3 ×  l0  s HT-2 cells, a T 
cell line developed by Dr. J.  D.  Watson,  Auckland U.  Sch. of Med.,  whose growth is 
completely dependent on IL2 (a  kind gift of Drs.  Kappler and Marrack,  Natl. Jewish 
Hosp., Denver, CO). [SH]thymidine was added 24 h later to measure proliferation. 
Lymph Node Proliferation Assay.  Lymph node proliferation assays were done as previ- 
ously reported (7). Animals were immunized in complete Freund's adjuvant in the hind 
footpads. Popliteal and inguinal  lymph nodes were collected 7-9 d  later,  teased,  and 
passed over nylon wool. The 4  x  10~nylon wool passed lymph node cells plus 1 x  105 
irradiated (2,000 R) normal spleen cells were cultured with varying amounts of antigen 
and pulsed with 1 pCi of [3H]thymidine and harvested. 
Results 
The  primary goal  of this  work  was  to  identify which  of the  five structural 
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TABLE  I 
Sequences of Peptides Used in this Work 
Name  Sequence*  Code 
81  9t  101 
Pigeon 81-104 
des-Alal°S-P 81-104 
des-Alal°S-P 87-104 
Moth 81-103 
Moth 88-I03 
Splice  (M  86-90,  P 
94-104) 
des-Alal°S-Splice 
GlngLSplice 
Glnga-des_Ala  I°s- 
Splice 
I  F  A  G  I  K  K  K  A  E  R  A  D  L  1  A  Y  L  K  Q  AT  A  K 
'A 
A 
A  N-  A 
A  N-  A 
K  K  A  N  E 
KKANE  A 
KKANE  Q 
KKANE  Q  A 
P 
DAPsl 
DAPs7 
Msl 
Msa 
Sp 
DASp  Q~ 
DAQ  99 
* The single  letter code is used:  A, alanine; D, aspartic acid;  E, glutamic acid;  F, phenylalanine; G, glycine;  I, isoleucine;  K, lysine; L, ieucine; 
N, asparagine; Q, glutamine; R, arginine; T, threonine; V, valine; Y, tyrosine;  A, deletion. 
prevented B10.A(5R) APC from presenting the pigeon peptide. Earlier analysis 
(10)  of the  pigeon  cytochrome c peptide  antigen  had  shown  that  changes at 
residues 100 and  104 could strongly affect antigen function. Thus, we focused 
initially on the deletion at position  103. In order to examine the contribution of 
this structural change, we synthesized two des-Ala-pigeon peptides, DAP87 and 
DAPsl (see Table I), which were identical in sequence to pigeon except at  103, 
where they both lacked an alanine. 
Fig.  1A  shows that moth-primed B10.A(5R)  lymph node cells responded to 
both these synthetic peptides, DAPsl and DAP87, almost as well as they responded 
to the moth fragment immunogen and  10,000-fold better than they responded 
to  the  pigeon  fragment.  Thus,  the  secondary  response  of  moth-primed 
B10.A(5R) T-cells showed this strain to be a high responder to DAP81 and DAP87 
but not to pigeon.  Fig.  1B shows the results of the test of B10.A(5R)  DAPsl- 
primed lymph node cells. A strong secondary response to DAP81 was seen that 
cross-reacted fully with moth 81-103 (Ms1) and moth 88-103 (Mss) but not with 
AmMss or pigeon 81-104  (P).  These results therefore show that it is solely the 
presence of the Ala 1°3  that  prevents the pigeon  peptide from being a  strong 
antigen or immunogen in B 10.A(5R) mice. 
Previously it has been demonstrated (6) that there is an antigen-specific defect 
in B10.A(5R) APC in that they present the pigeon fragment 81-104 poorly to 
pigeon-primed  B10.A  peritoneal  exudate  T  lymphocytes (PETLES)  but  can 
present Ms1  to this population.  We naturally wished to determine whether this 
antigen-specific defect in presentation to B10.A  T  cells also depended on the 
Ala 1°~ deletion. The data in Table II showed this to be the case. Pigeon-primed 
B10.A  PETLES  were  stimulated  with  APC-enriched  BI0.A  and  B10.A(5R) 
splenocytes that  had  been  precultured  with  either  moth,  pigeon,  or  DAP8~ 
fragments (antigen pulsed) or with  medium control.  The B10.A  APC  caused 
marked stimulation with all three of the test peptides. B10.A(5R) APC caused 
proliferation with DAP81 and moth; however, there was no B10.A(5R)-pigeon 
response above  the  medium control.  Thus,  the  Ala 1°3  residue prevented the 
effective presentation of the pigeon peptide by B10.A(5R) APC in this case to HANSBURG  ET  AL.  29 
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FIC.URE  1.  The specificity of the immune response of B10.A(5R) mice. BI0.A(5R) mice were 
immunized with 50 ug of moth 81-103(A) or des-Alal°S-pigeon (DAPal) (B). After 9 d nylon 
wool passed lymph node cells were cultured with varying concentration of the antigen peptides 
for 72 h. During the last 12 h  1 #Ci of [SH]thymidine was present. Antigens: des-AlalOS-pigeon 
81-104  (DAPa~, I-'1), moth  81-103  (Mal,  @),  Am moth 88-103  (AroMas,  O), moth 88-103 
(Maa, &), des-Ala]°S-splice  (DASp, ~7), des-Alal°S-pigeon 87-104,  (DAPs~,  0),  pigeon 81-104 
(P,  A).  Media controls: A,  8,300  _+  3,500; B,  1,900  ±  800;  PPD  stimulation: A, 67,700  ± 
5,800; B, 81,600 ±  3,600 (cpm +  SEM). 
TABLE  II 
BIO.A(5R) APe Can Present DAPs1 but Not Pigeon to BIO.A PETLES* 
APex  Antigen§:  Ms~  P  DAPs=  Medium 
BI0.A  90.6 ±  3.61  41.1  _+ 3.8  69.8 +  13.7  I0.1 ±  2.0 
BI 0.A(5R)  113.9___7.3  17.1  +3.0  73.5±7.7  17.3±0.7 
* B10.A mice were primed with  5 ~tg of pigeon 81-104  and peritoneal exudates  induced.  Nylon 
wool passed peritoneal exudate T  lymphocyte-enriched cells (PETLES) were cultured for 96 h. 
During the last 12 h  1 ttCi of [SH]thymidine was present. 
* The antigen-presenting cell (APe) enriched fraction of Percoll separated spleen cells was precuhured 
with  antigen  (10  ttM),  extensively washed  and  then  co-cultured  with  PETLES  lymphocytes.  A 
titration of APC (1.6  ×  l0  s,  8  ×  l0 s, 4  ×  104/well) were tested. The data from the point which 
gave optimum antigen-dependent stimulation with syngeneic APC is reported, in this experiment 8 
×  I 0S/well. 
Codes as given in Table I. 
! PETLES cultures were harvested on to glass filters and counted. Mean _+ SEM (x 10 -s) of triplicate 
cultures are given. 
allogeneic B10.A T  cells. 
We next considered whether this APC defect represents a change in specificity 
of the immune response or merely a change in its sensitivity. This latter possibility 
was  suggested  by  the  observations  that  higher  doses  of moth  fragment  are 
required to prime B10.A(5R) than the B10.A (data not shown) and that lymph 30  ANTIGEN-PRESENTING  CELL-EXPRESSED  SPECIFICITY 
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FIGURE  2,  The response of BI0.A(5R) anti-moth 81-I03  PETLES  to varying numbers of 
antigen precultured (pulsed) BI0.A Percoll-enriched APC. Experimental details as in Table 
III. Antigens: moth 81-103 (Ms~, 0); pigeon 81-104 (P, &); acetimidyl moth 81-103 (AmMs~, 
O). Medium controls 1.6 x  10  s APe/well: 6,300 :t: 670; 8 ×  10  s APe/well: 18,500 ±  2,270; 
4 x  104 APC/well: 26,900 ±  3,640. 
node cells and hybridomas respond to moth fragment at  100-fold lower doses 
on B 10.A-presenting cells then B 10.A(SR) APC (5). That is, even those peptides 
to which both B 10.A and B10.A(5R) are responders, are presented more effec- 
tively by B10.A APC. 
Whether there was also a specificity change could be considered by noting that 
in moth-primed B 10.A(5R) mice the acetimidyl derivative of moth 81-103 (Am- 
moth) is a  weak antigen but clearly stronger than pigeon (Fig.  1A); while in a 
pigeon or moth-primed B 10.A, the pigeon 81-104 peptide is a stronger antigen 
than  Am-moth  (data  not  shown).  If a  change  of relative  strengths  of these 
antigens  were  found  when  B10.A  and  B10.A(5R)  antigen-pulsed  APC  were 
compared, this would be evidence of a change in specificity. Fig. 2 reports the 
response curves of moth-primed B 10.A(5R)  PETLES to antigen-pulsed B 10.A 
APC. There is clearly a reversal of the relative strengths of pigeon 81-104  (P) 
and acetimidyl moth between  Fig.  1 A  and  Fig.  2.  Results  from this  type of 
experiment are  summarized  in  Table  III.  Shown  in  Table  III,  Exp.  I  is  a 
comparison of the response of moth-primed PETLES to Am-moth and pigeon- 
pulsed B10.A  and  B10.A(5R)  APC and illustrates the reversal of pigeon and 
Am-moth. The reciprocal experiment using Am-moth primed B10.A(5R) and 
Am-pigeon primed  B10.A  PETLES  was  performed and  yielded an  identical 
result (Table III, Exps.  II and III). In these experiments B10.S(9R) APC were 
also tested. These APC failed to present the Am-pigeon fragment to any appre- 
ciable  extent,  indicating that  the altered  specificity was  not  the  result  of an 
allogeneic effect. These results made clear that there was a  difference in  the 
specificity of the B10.A(5R) PETLES response to B10.A and B10.A(5R) APC. 
The results in Table III further suggested that the role of Ala ~°3 in governing 
the  ability  of  B10.A  and  B10.A(5R)  APC  remained  unchanged  when  two HANSBURG  ET  AL.  31 
TABLE  III 
Antigen Specificity Depends on the MHC of the APC 
Exp. I: BI0.A(SR)anti-moth PETLES* 
APC  Medium  Mst  AmMsl  P 
B10.A(5R)  1.0 +  0.4  77.4 :!: 2.5  22.6 +  0.8  >  8.0 ±  0.6* 
B10.A  4.5 ±  4.0  76.7 ±  4.1  55.9 ±  0.3  ~  68.3 ±  0.5 
B10.A(4R)  1.7 ±  0.1  3.8 ±  3.4  NT  3.3 ±  0.1 
Exp. II: BI0.A(5R) anti Am-moth PETLES 
Medium  AmM88  M88  AmP  AmDAPst 
B10.A(5R)  0.7±0.1  43.1±1.5  11.0±2.1  >  3.4±0,7  37.1±2.3 
B10.A  5.6 ±  0.3  31.7 ±  0.8  8.1  ±  1.9  <  32.5 ±  3.1  29.9 ±  2.6 
B10.S(9R)  8.5 ±  0.5  13.8 ±  0.9  8.8 ±  1.0  10.7 ±  3.3  12.8 ±  1.1 
Exp. III: BI0.A anti Am-pigeon PETLES! 
Medium  AtoM88  M88  AmP  AmDAPsl 
BI0.A(5R)  2,1  ±  0.4  33.1  ±  1.6  12.7 ±  0.6  >  6.9 ±  1.5  40.1 ±  4.5 
B10.A  1.3 ±  0.2  27.1  ±  2.9  10.8 ±  0.4  <  30.0 ±  1.2  27.9 ±  3.9 
B10.S(9R)  4.1±0.3  11.8±1.2  4.9±1.1  6.2±1.1  16.5±1.4 
* B 10.A(SR) mice were immunized with 50 eg of either moth 81-103 or acetimidyl moth 81-103. 
Otherwise as in Table II. 
* The changes in rank-order of antigen strengths are boxed and indicated. 
t B 10.A mice were primed with 10 t~g of pigeon 81-104. 
NT, Not tested. 
different T  cell specificities were examined, moth and Am-moth. This possibility 
was explored in more detail utilizing an observation reported elsewhere, ~ which 
indicated  that  T  cell  memory  was directed  primarily  toward residue-99.  Two 
new immunogens in addition to the Lys  99 specificity, were synthesized and tested: 
AmDASp, which shares Am-Lys 99 with Am-moth, and AmDAQ 99 (Gin99).  Fig. 3 
shows  that  for  B10.A(SR)  mice  these  two  peptides  cross-reacted  neither  with 
each other nor with the Lys  99 containing DAPsl peptide. Interestingly AmDAQ 99 
and DAQ 99 cross-reacted well (compare Fig. 2B and Fig. 1 A), indicating that the 
antigenically significant site of acetimidation was position 99. Also shown in Fig. 
3 are the failure of the Alal°3-containing analogues of these immunogens, AmSp 
and  AmQ 99,  to  stimulate.  The  ability  of  DAQ 90  to  stimulate  moth-primed 
B10.A(5R)  lymph node cells  was assessed and found to be negligible  (data not 
shown). Thus, AmDASp/AmSp  (Am-Lys 99) and AmDAQ99/AmQ 99 (Gin  99) are 
two pairs of peptides,  antigenically  distinct from  moth or  DAP and from each 
other,  whose antigenicity  in the B10.A(5R)  exactly parallels those of the DAP/ 
pigeon pair. 
To test whether the B10.A(5R)  T  cells could respond to the Alal°3-containing 
peptides in association with B10.A APC, the response of B10.A(5R)  PETLES to 
syngeneic  and allogeneic  antigen-pulsed  APC  was  tested.  These  experiments, 
(Table IV), show that the Alal°3's roles in the presentation  of pigeon and of the 
two new antigens were identical.  Thus, in each case the B10.A  APC presented 
Hansburg, D., T. Fairwell, R. H. Schwartz, and E. Appella,  1983.  The T  lymphocyte response 
to cytochrome c IV. Distinguishable sites on a peptide antigen  which affect antigenic strength and 
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FIOURE 3.  B10.A(5R) mice distinguish acetimidyl-des-Ala~°~-splice  (AmDASp) and acetimi- 
99  10~.  99  103  dyl-Gln  -des-Ala  -splice  (AmDAQ) from each other and from des-Ala  -pigeon (DAPsz). 
B10.A(5R) mice were primed with 50 #g of AmDASp(A) or AmDAQ99(B)  and then tested as 
in Fig. 1. Antigen identification is given in Table I. Media controls: A, 2,000 _  100; B, 2,900 
± 600; PPD stimulation: A, 72,500  4- 16,500; B, 106,900 +  10,000. 
TABLE  IV 
B I O.A(  5R) PETLES Respond to Ala ~°~-Containing Peptides with 
BIO.A but Not BIO.A(5R) APC* 
BI0.A(5R) anti Am-des-Alal°3-Splice  (AmDASp) PETLES 
Medium  AmDASp  AmSp 
B10.A(5R)  1.9 --. 0.2  42.0 +  1.0  3.6 ± 0.2 
B10.A  6.2 + 0.4  55.4 ±  1.3  24.3 +  1.4 
B10  3.2 4- 0.8  4.4 _ 0.5  4.3 + 0.5 
B10.S(9R)  10.9 + 3.3  16.9 4- 1.5  12.0 _  0.6 
B 10.A(5R) anti-Am-Gln99-des-Alat°3-Splice  (AmDAQ  99) PETLES 
Medium  AmDAQ  09  AmQ  99 
B10.A(5R)  1.5 ± 0,2  34,1 4- 3.3  2.3 + 0.1 
B10.A  28.5 ± 3.9  63.2 4- 9.3  58.1 + 3.7 
B10  7.5 ± 0.9  10.1 ± 2.0  NT 
B10.A(4R)  34.9 4- 3.7  35.0 4- 1.8  NT 
* Experiments performed as in Tables II and III. 
both Ala]°3-containing  and des-Alal°~-peptides while the  B10.A(5R) APC were 
able to stimulate only with the des-Ala 1°3 form. C57B1/10 and B10.A(4R)/(IE  b) 
APC were not able to stimulate at all, indicating that the AeE~ Ia molecule was 
utilized.  Likewise  B10.S(9R)(IE  k)  APC  failed  to  present,  indicating that  even 
among  mice  expressing  an  AeE~  molecule antigen recognition was  MHC  re- 
stricted.  Taken  together,  the  data  presented  above  indicate  that  for  three 
separate  T  cell  specificities  (Lys  99,  Am-Lys  99,  Gln  99)  there  was  a  consistent HANSBURG  ET  AL.  33 
antigen-specific defect in the ability of the B10.A(5R) APC's function, namely 
its  disruption  by  the  Ala l°s  insertion.  That  this  defect  lay  in  the  APC  was 
established by the B10.A APC's ability to present the Ala~°3-containing peptides 
to the same T  cell population.  These data suggest that there is an interaction 
between the restriction element (the AeE~ Ia molecule in this case) and nominal 
antigen. 
It  must  be  considered  that  all  the  residues  on  the  nominal  antigen  that 
participate in this interaction cannot be defined with present techniques. The 
identification of the site of this interaction depends on the availability of an MHC 
degenerate T  cell.  Even so,  only the differences in  antigen-MHC  interaction 
between the degenerate haplotypes can be identified. The previous data make 
clear that there was a difference between B10.A and B10.A(5R) in their ability 
to tolerate the insertion of Ala 1°3. The B10.A was permissive for this change. 
The B 10.A(5R) was restrictive. In contrast acetimidylation of the ~-amino groups 
had in these experiments a pronounced effect on the T  cell clones activated, i.e., 
on T  cell memory, but did not appear to affect the antigen-MHC interaction. 
We next considered the possibility that different T  cell clones might reveal 
different APC polymorphisms. This possibility was explored using two hybridoma 
clones. The first, labeled A in Table V, is derived from the fusion ofa B10.A(2R) 
Am-pigeon primed  lymphocyte and  BW5147.  Clone A  behaved as  would  be 
predicted from the data reported above for lymph node and PETLES T  cells. It 
responded to AmMss and AmDAP on both B10.A and B10.A(5R) APC but not 
to any nonacetimidated peptide.  It responded to Am-pigeon on B10.A alone. 
The second hybridoma, labeled B, is the B 10.A(5R) anti-moth fragment 81-103 
clone previously investigated (5).  Clone B  showed the same specificity as  the 
TABLE  V 
BIO.A(5R) APC are Blocked by Ala ~o~ Uniformly but by am-Lys Variably* 
Antigen 
Clone:  "A"(B10.A anti-AmP)  "B"(B10.A(5R) anti-B-Moth)* 
APC:  B10.A(5R)  B10.A  B10.A(5R)  B10.A 
Medium  0 |  0  0  0 
Mss !  0  0.1/0.1  11.5/9.9  103.8/94.6 
DAP81  0  1.0/2.5  47.3/66.1  73.2/84.2 
Pigeon  0  0  0  107.0/132.9 
AmM88  32.8/36.5  82.5/66 t. 1  0  80.5/85.6 
AmDAPsl  97.8/101.5  85.3/81.6  0  83.5/78.4 
AmPigeon  0  89.8/107.8  0  112.7/101.9 
DAQ  99  NT  NT  0  1.4/6.5 
* Hybridomas between BW5147 and antigen-stimulated T  cells as indicated were cultured with 2 x 
105 spleen cells and antigen in 0.25 ml of medium as previously described (5). IL2 production was 
induced by some antigen/APC combinations and detected by a secondary culture with 50% fresh 
medium and 3 x  103 HT-2 cells/0.2 ml. 
* Clone "B" is subclone of the B10.A(5R) anti-q-benzyl-moth hybridoma previously reported (5). 
0 After 24 h of culture  1 #Ci [3H]thymidine was added to the secondary HT-2 cultures which were 
harvested 4 h later. Cpm x  10 -3 of duplicates are given except when each are <100 cpm which is 
reported as 0. 
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B10.A(5R) anti-moth fragment 81-103  PETLES when it was tested with  Mas, 
pigeon, and  DAP fragments.  However, there was an additional  difference be- 
tween B10.A and B10.A(5R) APC that was revealed by testing of the acetimidyl 
derivatives of the Maa and DAP peptides. The APC from B10.A presented both 
acetimidyl and native Mss and DAP81 while B 10.A(5R) APC function was limited 
to only the unmodified peptides. The differences between B 10.A and B 10.A(5R) 
APC's stimulation of clone B illustrates once again the relative stringency of the 
B10.A(5R) antigen-MHC interaction compared with the B10.A. Yet, the ability 
of B10.A(5R) to present the acetimidyl peptides to some T  cells, e.g., our clone 
A, but not clone B indicates that the MHC-controlled, APC-expressed specificity 
of the  antigen-MHC  interaction  might  be determined,  in  part,  by the  T  cell 
population. 
This question, i.e., the relationship between the T  cell and the antigen-MHC 
interaction site that can  serve that  T  cell, can  perhaps  be better answered by 
knowing the  correlation between  the  MHC-controlled APC-expressed antigen 
specificity  and  immune  responsiveness.  If  one  assumes  that  the  interaction 
between  antigen  and  MHC  was  for the  most  part  independent  of the  T  cell 
population,  then,  since  B10.A(5R)  APC  were  unable  to  present  the  Ala 1°3 
containing peptides to des-Alal°3-primed B10.A(5R) T  cells, one would expect 
that the B10.A(5R) should be a  low responder to all these peptides.  The data 
presented in Table VI test this hypothesis. It shows that B10.A(5R) responded, 
in general, very poorly to the Alal°Lcontaining peptides. The largest response, 
to the moths6_90, pigeon94-104 splice peptide (Sp) was roughly two-fifths that  of 
PPD, while responses to the des-Alal°3-peptides were usually twice that. Further, 
no response to the Alal°Lcontaining peptides was seen at 1.0 #M while responses 
to mice primed to the des-Alal°S-peptides were evident as low as  10  -1 #M (Figs. 
1 and 3). Lastly, the low level of the B10.A(5R) anti-Sp response has not allowed 
TABLE  VI 
B IO.AOR) Was a Low Responder to Ala l°S-Containing Peptides* 
Strain  2 ° Antigen  [Ag] in vitro 
Immunogen 
Splice  AmSplice  AmQ  99 
B10.A(5R)  Medium  2.5 4- 0.2*  3.2 4- 0.1  4.5 4- 0.3 
Purified protein de-  59.2 4- 1.0  82.2 4- 6.4  84.9 + 1.8 
rivative (PPD) 
Immunogen  15 #M  23.2 4- 1.0  7.1 + 1.0  5.8 4- 0.8 
1.0 #M  3.5 4- 0.6  3.3 ± 0.4  5.5 4-  1.0 
des-Alal°L  15 #M  8.0 ± 1.1  9.3 4- 1.9  5.6 4- 1.8 
Immunogen  1.0 #M  6.6 4- 0.3  4.1 ± 0.7  5.3 +  1.4 
BI0  Medium  1.0 4- 0.3  0.8 4- 7.8  1.1 4- 0.1 
PPD  94.8 4- 4.6  83.5 ± 7.8  85.9 4- 4.0 
Immunogen  15 #M  1.1 4- 0.5  1.5 4- 0.1  2.1 4- 0.8 
* B10.A(5R) and B10 mice were immunized with 50 #g of the peptides indicated. Nylon wool passed 
lymph node cells were placed in culture on day 9. Cultures were stimulated with 15 #M or 1.0 #M 
of the immunogen, similar concentrations of the immunogen's des-Ala~°S-analogue,  50 #g/ml PPD, 
or the medium control. 
*  At 72 h 1 #Ci [SH]thymidine  was added to the cultures and harvested 16 hrs later. The mean cpm 
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TABLE  VII 
BIO.AOR) APC Can Present AmQ  99 to BIO.A PETLES* 
APC  Medium  AmDAQ  99  AmQ  ~ 
Exp. I 
BI0.A  2.0 -1- 0.7  85.4 ± 1.5  99.8 ± 16.3 
B10.A(5R)  18.4 ± 3.0  36.2 ± 2.4  39.4 ± 13.3 
B10.A(4R)  2.6 ± 0.6  5.8 ± 2.0  3.4 ± 1.6 
Exp. II 
BI0.A  3.9 ± 0.9  91.7 ± 8.0  160.7 ± 7.8 
BI0.A(5R)  7.9 ± 0.5  21.5 ± 2.9  30.8 ± 3.3 
Exp. III 
B10.A  6.8 ± 0.9  114.6 ± 10.2  111.3 ± 8.6 
B10.A(5R)  13.2 ± 1.0  32.2 ± 3.4  40.7 zl: 0.5 
BI0.A(4R)  NT  NT  4.0 ± 0.5 
* BI0.A mice were primed with 50 #g of acetimidyl-Q  ~ (Exp. I and II) or Q99 
(Exp. llI). Experiments performed as in Table II. 
us to test its specificity beyond noting that there is no heteroclitic stimulation by 
DASp. In particular, there is no evidence that the site of T  cell memory contains 
residue-99.  Thus,  there  is  an  excellent  correlation  between  the  low  immune 
responsiveness  of B10.A(5R)  to  the  Alal°3-containing  peptides  and  the  poor 
ability of its APC to present them to des-Ala~°~-primed T  cells. 
A marked response to the AmQ  99 peptide in B10.A and B 10.S(9R) mice could 
be obtained. ~ If immune response differences do in fact reflect only the capacity 
of the APC to interact with antigen, and this capacity were independent of the 
T  cell test population,  one would excpect that  B10.A(5R)  APC would present 
AmDAQ  99 but  not  AmQ 99 to AmQ99-primed  B10.A  PETLES.  The  data  pre- 
sented  in  Table  VII  show  three  experiments  in  which  this  was  not  the  case. 
Rather, there was significant and largely equivalent presentation of both AmQ  99 
and  AmDAQ 99  to  some  fraction  of  the  BI0.A  PETLES  even  though  the 
B 10.A(5R) was essentially a  nonresponder to AmQ  99 and a strong responder to 
AmDAQ  99. Again B10.A(4R) failed to present, indicating a requirement for the 
AeE~ Ia molecule. Note particularly that Table II and Table VII present com- 
parable experiments examining the effects of the Ala ~°3 insertion on the ability 
of B10.A(5R)  APC  to  present  two  different antigens  to  B10.A  T  cells.  The 
results found were,  in  fact, opposite:  B10.A(5R)  APC can present AmQ  99 but 
not  the  pigeon  81-104  fragment.  These  data  suggest  that  there  may be  two 
mechanism  of  Ir  gene  effects.  For  one  type,  of which  the  B10.A(5R)  poor 
response to pigeon 81-104 is an example, low responsiveness is explicable solely 
on the basis of the APC-expressed antigen specificity. For the second type, e.g., 
B10.A(5R)  anti-AmQ 99,  both  repertoire and  APC  specificity appear  to be  in- 
volved. 
Discussion 
The data presented in this work address two questions: Does the B10.A(5R)'s 
low responsiveness to the Ala~°3-containing peptides correlate with some limita- 
tion  of its  APC  function?  If so,  is  this  the  only cause  of the  B10.A(5R)  low 36  ANTIGEN-PRESENTING  CELL-EXPRESSED  SPECIFICITY 
responsiveness? 
The answer to the first question is emphatically yes. The correlation between 
the B10.A(5R)'s poor responsiveness to the Ala~°3-containing peptides as immu- 
nogens and the poor response of des-Alal°3-primed B10.A(5R) PETLES to the 
Ala~°3-containing peptides on B10.A(5R) but not B 10.A APC is the fundamental 
observation of the present work. As has been reported previously (7,  13) and in 
Table VI of this report, B10.A(5R) is a low but not a complete nonresponder to 
the five Ala~°S-containing peptides tested (pigeon, Am-pigeon, splice, AmSp, and 
AmQ99).  In each case the B10.A(5R) T  cells that have been primed with a des- 
Ala~°3-peptide are able to respond well to the Alal°3-containing peptides when 
B10.A  APC  are  used,  but  poorly  with  its  own  B10.A(5R)  APC.  From  the 
examination  of the  B10.A(5R)  PETLES  we  might  conclude that  there  is  an 
antigen-specific defect of the presenting cell with an antigen structure-function 
relationship that  is  independent of the specificity of the T  cell clone used to 
detect it. Although most of our data indicated that the APC-expressed antigen 
specificity did not depend on the test T  cell population, analysis of the hybridoma 
clone B yielded an apparent exception. However, this exception is difficult to 
interpret because it was revealed by peptides that had been modified by acetim- 
idate  at  two  sites:  residue-99,  the  site  of T  cell  memory,  and  the  carboxyl 
terminus. The resulting specificity pattern is fairly complex. Although clone B 
responds to neither AmDAP or Am-moth fragment 81-103 on B10.A(5R) APC, 
it is not completely unresponsive to peptides with Am-Lys at 99 and  103.  For 
example,  it  responds  well  to  Am-fly  fragment  81-103  in  association  with 
B10.A(5R) APC (5).  Because, in this case, changes in specificity and sensitivity 
can not be carefully separated, we feel the question of whether additional residues 
affect APC-expressed antigen specificity should be deferred until further data 
can be obtained. 
Examination of the immune response to the peptides with Gin  99 addresses the 
second question: whether the APC-expressed antigen specificity is the exclusive 
cause of Ir gene effects. As is shown by the comparison of Table VII and Table 
IV,  the  T  cell  repertoires  to  the  Gin99-containing  peptides  appear  to  differ 
between B10.A and B10.A(5R). The B10.A possesses clones that can respond to 
AmQOg-B 10.A(5R) but the B10.A(5R) does not. This result is completely analo- 
gous to the earlier reports of allogeneic T  cells being able to respond to antigen 
on low responder APC (14-18). The difference is that previously low responder 
APC,  allogeneic  to  the  T  cell  source,  were  used  for  both  priming and  the 
secondary assay; whereas, in the present case, the degeneracy of the B10.A anti- 
AmQ  99 T  cells allowed syngeneic priming. In either case, the data indicate that 
differences in T  cell repertoires can be the cause of Ir gene effects. 
In our opinion, the significant points to be made from the present work are as 
follows. Duplicate experiments have been performed with two different pairs of 
antigens: (a)pigeon/des-Alal°~-pigeon; (b)AmDAQ99/AmQ  99.  In the first case 
the immune response differences between B 10.A and B 10.A(5 R) appear entirely 
attributable  to  APCoexpressed antigen  specificity. The  second  case  is  clearly 
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the same APC-expressed antigen specificity as seen in (1). However, examination 
of the B10.A anti-AmQ  99 response indicates additional clones are present for 
this antigen in the B 10.A that are absent in the B 10.A(5R). Thus APC-expressed 
antigen specificity is demonstrable and correlates with differences in  immune 
responsiveness, but is not the sole cause of immune response polymorphisms. 
Lastly, some brief speculation on the mechanism of MHC-controlled, APC- 
expressed specificity may be useful. The simplest, and therefore most attractive, 
hypothesis is that the nominal antigen and the Ia region gene products physically 
interact through a site that contains the Alal°3-deletion (6) and that the site on 
the nominal antigen of this interaction depends only on the location of the site 
of T  cell  memory (the T  cell epitope),  not on  its particular structure.  In the 
present case the putative site of  interaction would be characterized by the B 10.A's 
ability to accept Ala ~°s or its deletion while the B10.A(5R) is apparently able to 
present only the des-Ala-peptides well. The hypothesis is in good agreement with 
all  the  data  except  the  AmQ99-primed  B10.A  T  cell  subpopulation,  which 
recognizes AmQ  99 and AmDAQ  99 equally well with B10.A(5R)  APC.  Further 
investigations to determine which residues, in addition to 99, contribute to the 
site of T  cell memory will allow us to compare the location and extent of the T 
cell epitope for clones both of the B10.A anti-Lys  99 and the B10.A anti-Gin  99 
responses  that  recognize antigen  in  association  with  B10.A(5R).  These  data 
should provide a further test of the hypothesis. 
Summary 
In previous work (5, 6), we have reported studies on a T lymphocyte hybridoma 
clone and the peritoneal exudate T cells (PETLES) from B 10.A(5R) mice primed 
with the cytochrome c carboxyl terminal peptide (residues 81-103) of the tobacco 
horn  worm  moth  (Manducca sextus). As  expected,  since  B10.A(5R)  is  a  low 
responder to pigeon fragment 81-104, it was found that the B 10.A(5R) lympho- 
cytes were  unable  to  respond  to  the  pigeon  cytochrome c  81-104  fragment 
presented  on  syngeneic B10.A(5R)  antigen-presenting cells  (APC).  However, 
these same T  lymphocytes did respond to the pigeon fragment when presented 
on B10.A APC. Thus, some structural difference between the pigeon and moth 
peptides had prevented B 10.A(5R) APC from effectively presenting the pigeon 
fragment to  moth-primed B10.A(5R)  lymphocytes. This  structural  difference 
was found to be the deletion of an alanine at position  -103  (Ala 1°3) from the 
pigeon sequence in the moth peptide. Two additional T  cell specificities were 
created by changing residue-99. These T  cell populations from the B10.A(5R) 
showed  an  identical  dependence  on  the  Ala 1°3  deletion  when  B10.A  and 
B 10.A(5R) APC were compared. 
The relationship of APC-expressed antigen specificity and  MHC-linked im- 
mune responsiveness differences was also examined. The B10.A(5R) was found 
to be a high responder to each of three peptides that lack Ala ~°3 but not to the 
Ala~°3-containing analogues. B10.A mice, in contrast, respond to both types of 
peptides. Utilizing ailogeneic antigen-presentation to B10.A PETLES by pulsed 
APC,  it  was  shown  that  the  poor  response  of the  B10.A(5R)  to  the  Ala ~°~- 38  ANTIGEN-PRESENTING  CELL-EXPRESSED SPECIFICITY 
containing peptides was, in two of three cases, not associated with any differences 
in  T  cell repertoires but  due  to  two different APC  capabilities  of B10.A and 
B10.A(5R).  The  exception  apparently  represents  a  case  of T  cell  repertoire 
polymorphism  between  B10.A  and  B10.A(5R)  that  can  also  affect  immune 
responsiveness. 
We wish to thank Dr. R.  H. Schwartz for his advice and suggestions throughout these 
studies. Dr. Matthew Pincus provided invaluable aid in the choice of variant sequences. 
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